United Kingdom: NICE National Institute for Health and Care Excellence

https://www.nice.org.uk/news/events/5-year-strategy-virtual-event-launch

 

Besides providing health guidelines what is the remit of NICE? If their leadership has decided to get serious about reality and providing the kind of guidance that reflects that what other influence do they have in the system that would bode well for thinking that there is a spreading effect through medicine in taking our kind of health issue seriously (in a realistic, finding what really works kind of way) ?

 

Maybe they should start by examining their role in IAPT and look again at the 'evidence';

https://www.nice.org.uk/about/what-we-do/our-programmes/nice-advice/iapt

 

The NICE strategy 2021 to 2026

Why now?
The world around us has changed and is evolving rapidly. If we’re to stay relevant and remain an international leader in our field, we need a strategy that anticipates, recognises and responds to future changes and challenges.

Added to this, the COVID-19 pandemic changed the UK health and care landscape significantly. The speed at which the crisis gripped our health and care system demanded a new type of response. One that required swiftness and flexibility with constant monitoring of, and reacting to, a changing situation. We rose to the challenge, and the pandemic provided a catalyst for the type of change that we already knew we needed to make.

What will be different?
We’ve developed a vision for the future where we will:

• Be at the forefront of anticipating and rapidly evaluating new and existing technologies to provide independent, world-leading assessments of value for the system and improved access for patients.
• Provide dynamic, living guideline recommendations that are useful, useable and rapidly updated. They’ll incorporate the latest evidence and newly recommended technologies to maximise uptake and access for patients.
• Drive the implementation of our guidance, forming key strategic partnerships to make sure it’s used. We’ll make sure it delivers improvements and contributes to reducing inequalities, with measures to routinely track adoption.
• Be scientific leaders, driving the research agenda and developing innovative and data-driven methods. We’ll use real-world data to resolve issues of uncertainty and improve access to new innovations for patients.
• Transform our organisation to make sure we have the infrastructure, skills and capacity to deliver our strategy. We’ll leverage the use of technology to maximise our efficiency and impact.

More at https://www.nice.org.uk/about/who-we-are/corporate-publications/the-nice-strategy-2021-to-2026

 

Doing 10/10 on the MBA buzzwords here. Ready the awards for maximizing the synergy of cost-relational benefits in implementing and strategizing wider horizons for impactful results and efficiency.

And other stuff. Just stamp one for Wessely out the gate, there seems to be some sort of automatic process by which he gets awards for no reasons anyone can actually explain.

 

seems like the kind of institutional marketing that happens before privatisation . possibly me just being sceptical .

 

https://twitter.com/user/status/1410146366953865216